A317 (Fenofibrate (Micronized) 67 mg)
Pill with imprint A317 is Yellow, Capsule-shape and has been identified as Fenofibrate (Micronized) 67 mg. It is supplied by Alembic Pharmaceuticals Inc..
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 67 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A317
Related Images for "A317"
More about fenofibrate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: fibric acid derivatives
- Fenofibrate (Advanced Reading)
- Fenofibrate and Derivatives Tablets
- Fenofibrate and Derivatives Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.